As of 2026-06-10, the EV/EBITDA ratio of Health Catalyst Inc (HCAT) is 8.75. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. HCAT's latest enterprise value is 183.85 mil USD. HCAT's TTM EBITDA according to its financial statements is 21.02 mil USD. Dividing these 2 quantities gives us the above HCAT EV/EBITDA ratio.
| Range | Selected | |
| Trailing P/E multiples | 8.0x - 10.1x | 9.0x |
| Forward P/E multiples | 8.3x - 17.9x | 13.3x |
| Fair Price | 1.42 - 5.37 | 2.67 |
| Upside | -16.9% - 213.9% | 55.9% |
| Date | EV/EBITDA |
| 2026-06-08 | 8.83 |
| 2026-06-05 | 9.30 |
| 2026-06-04 | 9.32 |
| 2026-06-03 | 7.79 |
| 2026-06-02 | 7.84 |
| 2026-06-01 | 7.94 |
| 2026-05-29 | 7.92 |
| 2026-05-28 | 7.97 |
| 2026-05-27 | 7.72 |
| 2026-05-26 | 7.61 |
| 2026-05-22 | 7.69 |
| 2026-05-21 | 7.69 |
| 2026-05-20 | 7.69 |
| 2026-05-19 | 7.64 |
| 2026-05-18 | 7.64 |
| 2026-05-15 | 7.44 |
| 2026-05-14 | 7.39 |
| 2026-05-13 | 7.82 |
| 2026-05-12 | 8.17 |
| 2026-05-11 | 7.92 |
| 2026-05-08 | 8.27 |
| 2026-05-07 | 8.44 |
| 2026-05-06 | 8.39 |
| 2026-05-05 | 8.47 |
| 2026-05-04 | 8.39 |
| 2026-05-01 | 8.09 |
| 2026-04-30 | 7.59 |
| 2026-04-29 | 7.64 |
| 2026-04-28 | 7.82 |
| 2026-04-27 | 7.89 |
| 2026-04-24 | 7.92 |
| 2026-04-23 | 7.79 |
| 2026-04-22 | 7.74 |
| 2026-04-21 | 7.77 |
| 2026-04-20 | 7.61 |
| 2026-04-17 | 7.77 |
| 2026-04-16 | 7.64 |
| 2026-04-15 | 7.54 |
| 2026-04-14 | 7.26 |
| 2026-04-13 | 7.11 |
| 2026-04-10 | 6.95 |
| 2026-04-09 | 6.99 |
| 2026-04-08 | 7.04 |
| 2026-04-07 | 7.21 |
| 2026-04-06 | 7.35 |
| 2026-04-02 | 7.39 |
| 2026-04-01 | 7.36 |
| 2026-03-31 | 7.64 |
| 2026-03-30 | 7.41 |
| 2026-03-27 | 7.21 |